Le Lézard
Classified in: Health, Covid-19 virus
Subject: SHA

Bulletin from the Extraordinary General Meeting of Essity

STOCKHOLM, Oct. 28, 2020 /PRNewswire/ -- The Extraordinary General Meeting today resolved in accordance with the Board's proposal to pay a dividend of SEK 6.25 per share.

The record date was set at October 30, 2020. The dividend is expected to be paid on November 4, 2020.

Pursuant to the temporary legislation in place due to COVID-19, the Meeting was held through a postal vote without the physical attendance of shareholders.

Minutes from the Extraordinary General Meeting will be available on the company website, www.essity.com, within two weeks.

For further information, please contact:

Per Lorentz, Vice President Corporate Communications, +46 8 788 52 51, per.lorentz@essity.com

Johan Karlsson, Vice President Investor Relations, +46 8 788 51 30, johan.ir.karlsson@essity.com

This information was brought to you by Cision http://news.cision.com


The following files are available for download:


Bulletin from the Extraordinary General Meeting of Essity


These press releases may also interest you

at 16:45
908 Devices, a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to...

at 16:35
CB2 Insights (CSE:CBII; OTCQB:...

at 16:15
Dr. Paul Lange, M.D., F.C.C.P., has been named medical director at Donor Alliance, the federally designated organ procurement organization serving Colorado and most of Wyoming. A board certified physician in pulmonary and critical care medicine,...

at 16:00
Amgen will present at the Evercore ISI Virtual HealthCONx Conference at 1:50 p.m. ET on Tuesday, Dec. 1, 2020. David M. Reese, M.D., executive vice president of Research and Development and Peter H. Griffith, executive vice president and chief...

at 16:00
E-Z-C Pak, the first physician formulated immune support pack composed of Echinacea, Zinc, and Vitamin C designed to reduce antibiotic overuse in cold and flu has surged in demand amid the COVID-19 outbreak. Company spokesperson Julianne Jahn...

at 15:28
Vivera Pharmaceuticals and Burkhan World today announce financial backing by JR Dallas Wealth Management in support of Vivera's global growth strategies. This ongoing partnership will provide financial services ? including debt and equity backing ?...

News published on 28 october 2020 at 07:44 and distributed by: